A panel discussion on non dilutive funding sources for biopharma and medtech startups from government research and industry grants to industry partnerships and venture debt.
Moderator: Stephen Nappi, Associate VP for Technology Commercialization and Business Development, Temple University
- Tom C.-C. Hu, Ph.D. MBA DABMP, Interdisciplinary Scientist/Project Officer, U.S. Department of Health & Human Services (HHS)
- Tiffany Wilson, President & CEO, University City Science Center
- Kelly Wylam, Director of Innovation Partnership, Ben Franklin Technology Partners